USD10
CMPX Shares
About Compass TherapeuticsCompass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
USD10
CMPX Shares
About Compass TherapeuticsCompass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$929.49M
OPEN PRICE
$5.40
LOW (1Y)
$1.33
HIGH (1Y)
$6.88
LOW (24H)
$5.14
HIGH (24H)
$5.44
VOLUME (24H)
$5.58M
179.9%
Price history
Time | Price | Change |
|---|---|---|
Today | $5.40 | |
1 Day | $5.23 | |
1 Week | $5.20 | |
1 Month | $6.32 | |
1 Year | $2.37 |
Past performance is not a reliable indicator of future results.